Northern Trust Corp Cocrystal Pharma, Inc. Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$1.08 - $2.14 $60,851 - $120,576	56,344 Added 64.67%	143,474 $179,000
Q1 2021 May 12, 2021	BUY	$1.3 - $2.35 $8,011 - $14,483	6,163 Added 7.61%	87,130 $121,000
Q4 2020 Feb 11, 2021	SELL	$0.8 - $2.16 $3,060 - $8,262	-3,825 Reduced 4.51%	80,967 $110,000
Q3 2020 Nov 16, 2020	BUY	$0.86 - $2.36 $8,908 - $24,447	10,359 Added 13.92%	84,792 $79,000
Q2 2020 Aug 14, 2020	BUY	$0.7 - $1.58 $27,412 - $61,872	39,160 Added 111.02%	74,433 $113,000
Q1 2020 May 14, 2020	BUY	$0.48 - $2.19 $9,859 - $44,982	20,540 Added 139.41%	35,273 $25,000
Q2 2019 Aug 13, 2019	SELL	$2.06 - $2.75 $2,401 - $3,206	-1,166 Reduced 7.33%	14,733 $35,000
Q1 2019 May 13, 2019	BUY	$2.65 - $4.14 $6,185 - $9,662	2,334 Added 17.21%	15,899 $43,000
Q4 2018 Feb 12, 2019	BUY	$1.6 - $3.68 $265 - $610	166 Added 1.24%	13,565 $49,000
Q3 2018 Nov 14, 2018	SELL	$2.3 - $4.95 $8,972 - $19,309	-3,901 Reduced 22.55%	13,399 $34,000
Q2 2018 Aug 14, 2018	BUY	$1.79 - $6.25 $30,967 - $108,125	17,300 New	17,300 $63,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.